0001593968-24-000195.txt : 20240131
0001593968-24-000195.hdr.sgml : 20240131
20240131174741
ACCESSION NUMBER: 0001593968-24-000195
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240125
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parker Geoffrey M.
CENTRAL INDEX KEY: 0001491874
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 24584174
MAIL ADDRESS:
STREET 1: 15 RIORDAN PLACE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
primary_01.xml
PRIMARY DOCUMENT
X0508
4
2024-01-25
0001737287
Allogene Therapeutics, Inc.
ALLO
0001491874
Parker Geoffrey M.
210 EAST GRAND AVE
SOUTH SAN FRANCISCO
94080
true
CHIEF FINANCIAL OFFICER
false
Common Stock
2024-01-25
4
A
false
29400
0
A
819400
D
Stock Option (Right to buy)
3.2
2024-01-25
4
A
false
103939
0
A
2034-01-25
Common Stock
103939
103939
D
1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter.
/s/Earl Douglas, Attorney-in-Fact
2024-01-31